Treating muscle wasting with selective androgen receptor modulators
Details for Australian Patent Application No. 2002364949 (hide)
International Classifications
Event Publications
31 July 2003 Complete Application Filed
Priority application(s): 60/336,185 06.12.01 US
28 August 2003 Application Open to Public Inspection
Published as AU-B-2002364949
22 February 2007 Application Accepted
Published as AU-B-2002364949
21 June 2007 Standard Patent Sealed
29 May 2008 Amendment Made
The nature of the amendment is as shown in the statement(s) filed 25 Jul 2007 2003
18 March 2010 Assignment Registered
GTX, Inc. The patent has been assigned to University of Tennessee Research Foundation
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2002364950-BETA-CYCLODEXTRIN DIMERS AND PHTHALOCYANINES AND USES THEREOF
2002364948-CRYSTALS AND STRUCTURES OF MEMBERS OF THE E. COLI COMA AND YDDB PROTEIN FAMILIES (COMA)
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional

- Editable Word format reports
- For IP Professionals
- Multiuser